Loading

logo

Journal of Allergy and Infectious Diseases

ISSN: 2692-6334

Case Report Open Access
Volume 2 | Issue 2 | DOI: https://doi.org/10.46439/allergy.2.023

Multisystem inflammatory syndrome in Adults (MIS-A)

Bertha Serwa Ayi1,*
  • 1Essentia Health West, 3000 32nd Avenue South. Fargo, ND 58103 USA
+ Affiliations - Affiliations

Corresponding Author

Bertha Serwa Ayi, serwabb@hotmail.com

Received Date: April 01, 2021

Accepted Date: July 19, 2021

Citation:

Ayi BS. Multisystem inflammatory syndrome in adults (MIS-A). J Allergy Infect Dis 2021; 2(2):42-45.


Copyright: © 2021 Ayi BS. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Abstract

SARS-CoV-2 virus infection causes a rare multisystem inflammatory syndrome in children (MIS-C) weeks after the acute infection. Clinicians need to know about a similar syndrome in adults- multisystem inflammatory syndrome in adults (MISC-A). A 38-year-old woman presented MIS-A and was effectively managed with intravenous human immune globulin (IVIG) administration supplemented by hydrocortisone sodium succinate.

Keywords

Multisystem inflammatory syndrome in Children, Multisystem inflammatory syndrome in Adults, MIS-C, MIS-A, Intravenous human immune globulin

Recommended Articles

Multisystem inflammatory syndrome in Adults (MIS-A)

SARS-CoV-2 virus is the cause of COVID-19 disease. This disease was initially thought to be a pure respiratory illness characterized by cough and fever however it soon became evident that it could cause kidney failure, strokes and involve multiple organ systems as the acute phase evolves into a cytokine storm 10-12 days after symptom onset [1] In April of 2020 reports from Europe [2] and United States highlighted MIS-C which occurs two to four weeks after the initial infection [3].

Full Text
Cite
Download PDF
Author Information X